BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
BHVN
Delisted
BHVN was delisted on the 3rd of October, 2022.
90 hedge funds and large institutions have $523M invested in Biohaven Pharmaceutical Holding Company Ltd. in 2017 Q4 according to their latest regulatory filings, with 29 funds opening new positions, 31 increasing their positions, 14 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
11% less capital invested
Capital invested by funds: $585M → $523M (-$62.6M)
17% less funds holding in top 10
Funds holding in top 10: 6 → 5 (-1)
Holders
90
Holding in Top 10
5
Calls
$4.24M
Puts
$872K
Top Buyers
| 1 | +$19.8M | |
| 2 | +$13.5M | |
| 3 | +$11.9M | |
| 4 |
PAMU
Pictet Asset Management (UK)
London,
United Kingdom
|
+$8.6M |
| 5 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
+$8.04M |
Top Sellers
| 1 | -$9.35M | |
| 2 | -$8.28M | |
| 3 | -$3.6M | |
| 4 |
GGHC
Gilder Gagnon Howe & Co
New York
|
-$2.79M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$2.04M |